Truxima®
ACTIVE PRINCIPLE:
Rituximab
INDICATION:
Rheumatoid Arthritis
Non-Hodgkins lymphoma
Chronic lymphocytic leukemia
Granulomatosis with polyangiitis
microscopic polyangiitis
DATE:
07/04/2017
STATUS:
Authorized
ACTIVE PRINCIPLE:
Rituximab
INDICATION:
Rheumatoid Arthritis
Non-Hodgkins lymphoma
Chronic lymphocytic leukemia
Granulomatosis with polyangiitis
microscopic polyangiitis
DATE:
07/04/2017
STATUS:
Authorized